Pharmacological stimulation of the parasympathetic system – a promising means of cardioprotection in heart failure.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Works by Baka, Tomas
Results: 20
1
2
Increasing mitochondrial ATP synthesis with butyrate normalizes ADP and contractile function in metabolic heart disease.
- Published in:
- NMR in Biomedicine, 2020, v. 33, n. 5, p. 1, doi. 10.1002/nbm.4258
- By:
- Publication type:
- Article
3
Sacubitril/Valsartan Alleviates Cardiac Remodeling and Dysfunction in L-NAME-Induced Hypertension and Hypertensive Heart Disease.
- Published in:
- Biomedicines, 2024, v. 12, n. 4, p. 733, doi. 10.3390/biomedicines12040733
- By:
- Publication type:
- Article
4
Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10081844
- By:
- Publication type:
- Article
5
Melatonin as a Potential Approach to Anxiety Treatment.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 16187, doi. 10.3390/ijms232416187
- By:
- Publication type:
- Article
6
Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 10, p. 3017, doi. 10.3390/ijms19103017
- By:
- Publication type:
- Article
7
The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760.
- Published in:
- Biological Research, 2023, v. 56, n. 1, p. 1, doi. 10.1186/s40659-023-00466-x
- By:
- Publication type:
- Article
8
Ivabradine reversed nondipping heart rate in rats with l‐NAME‐induced hypertension.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2019, v. 46, n. 6, p. 607, doi. 10.1111/1440-1681.13075
- By:
- Publication type:
- Article
9
Chronotherapy as a potential approach to hypertensive patients with elevated heart rate?
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 8, p. 1861, doi. 10.1111/bcp.14020
- By:
- Publication type:
- Article
10
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
- Published in:
- Clinical Science, 2021, v. 135, n. 8, p. 1009, doi. 10.1042/CS20210182
- By:
- Publication type:
- Article
11
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells.
- Published in:
- Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2022.842512
- By:
- Publication type:
- Article
12
Ivabradine curbs isoproterenol-induced kidney fibrosis.
- Published in:
- General Physiology & Biophysics, 2023, v. 42, n. 2, p. 209, doi. 10.4149/gpb_2022057
- By:
- Publication type:
- Article
13
Lisinopril reverses behavioural alterations in spontaneously hypertensive rats.
- Published in:
- General Physiology & Biophysics, 2019, v. 38, n. 3, p. 265, doi. 10.4149/gpb_2019011
- By:
- Publication type:
- Article
14
17β-Estradiol treatment reversed left ventricular dysfunction in castrated male rats: an echocardiographic study.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2018, v. 96, n. 8, p. 850, doi. 10.1139/cjpp-2017-0596
- By:
- Publication type:
- Article
15
Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.978337
- By:
- Publication type:
- Article
16
Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol‐induced myocardial injury.
- Published in:
- Fundamental & Clinical Pharmacology, 2021, v. 35, n. 4, p. 744, doi. 10.1111/fcp.12620
- By:
- Publication type:
- Article
17
Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review.
- Published in:
- Journal of Pineal Research, 2016, v. 61, n. 2, p. 127, doi. 10.1111/jpi.12348
- By:
- Publication type:
- Article
18
Chronotherapy of cardiovascular pathologies: a hopeful strategy.
- Published in:
- 2022
- By:
- Publication type:
- Letter
19
Chronotherapy of cardiovascular pathologies: a hopeful strategy.
- Published in:
- Therapeutic Advances in Chronic Disease, 2022, p. 1, doi. 10.1177/20406223221092372
- By:
- Publication type:
- Article
20
Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension.
- Published in:
- Molecules, 2018, v. 23, n. 2, p. 265, doi. 10.3390/molecules23020265
- By:
- Publication type:
- Article